Status:
COMPLETED
Levosimendan and Myocardial Protection
Lead Sponsor:
University of Roma La Sapienza
Collaborating Sponsors:
University College London Hospitals
Conditions:
Myocardial Protection
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of this study is to investigate whether pharmacological pre-treatment with levosimendan reduces intensive care unit (ICU) length of stay in patients undergoing elective myocardial revasculariz...
Eligibility Criteria
Inclusion
- age ≥18 years
- intention to perform first-time multi-vessel CABG
Exclusion
- unstable angina
- valvular disease
- diabetes mellitus treated with sulphonylurea drugs
- renal failure
- severe hepatic disease
- severe chronic obstructive pulmonary disease
- a history of prior CABG surgery
- recent myocardial infarction (MI) within the previous month
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00610350
Start Date
January 1 2005
End Date
February 1 2007
Last Update
February 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rome "Sapienza"
Rome, Italy, 00155